Capstone Investment Advisors’s Medicines Co MDCO Stock Holding History

Capstone Investment Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-700	Closed	-$59K	–	1459
2019 Q4	$59K	Sell	700 -30,600	-98%	-$2.04M	﹤0.01%	1329
2019 Q3	$1.56M	Buy	31,300 +20,500	+190%	+$818K	0.01%	793
2019 Q2	$394K	Buy	+10,800	New	+$353K	﹤0.01%	1155
2016 Q4	–	Sell	-7,800	Closed	-$294K	–	1183
2016 Q3	$294K	Buy	+7,800	New	+$294K	0.01%	611

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Capstone Investment Advisors's MDCO Position: Q1 2020 in Review

Capstone Investment Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 700 shares — an estimated $59K sold.

Capstone Investment Advisors first reported a position in MDCO in Q3 2016 and held it in 4 quarters. The position peaked at $1.56M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Capstone Investment Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Capstone Investment Advisors sold 700 Medicines Co shares in Q1 2020, an estimated $59K.
Capstone Investment Advisors first reported a position in Medicines Co in Q3 2016 and held it in 4 quarters.
Capstone Investment Advisors's Medicines Co position peaked at $1.56M in Q3 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Capstone Investment Advisors's 13F filing for Q1 2020, filed 15 May 2020.